Case report identifies immunohistochemistry's role in diagnosing osteoblastoma-like osteosarcoma, highlighting clinical complexities.
Introduction: Osteoblastoma-like osteosarcoma is a rare subtype of osteosarcoma, constituting only 1% cases. Due to its similarity with osteoblastoma in clinical, radiological, and pathological features, distinguishing between the two can be challenging. This study reports a rare case of osteoblastoma-like osteosarcoma in a 12-year-old girl, emphasizing the diagnostic challenges and the critical role of immunohistochemistry (IHC) in confirming the diagnosis. Case Presentation: A 12-year-old girl presented with pain and swelling in her right knee after a fall. Initially, the symptoms had been present for 6 months, with worsening pain over the last 2 months, requiring the use of a walking crutch. MRI findings raised suspicion of a Giant Cell Tumor (GCT), but core biopsy results suggested osteoblastoma-like osteosarcoma. Immunohistochemistry (IHK) for P53 was strongly positive, further supporting the diagnosis of osteoblastoma-like osteosarcoma. Clinical Discussion: Osteosarcoma and osteoblastoma-like osteosarcoma share many similarities, making diagnosis difficult. A thorough clinical evaluation, advanced imaging, and histopathological analysis, including IHC, are crucial for an accurate diagnosis. This case highlights the importance of a multidisciplinary approach, involving clinicians, radiologists, and pathologists, to establish the correct diagnosis and determine an appropriate treatment plan. Conclusion: Osteoblastoma-like osteosarcoma is a rare and challenging tumor to diagnose due to its similarity with other bone lesions. A multidisciplinary approach, along with the use of immunohistochemistry, is essential for accurate diagnosis and effective treatment.
No takes yet. Share an insight, caveat, or question.
Isma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: